eLesor Investments version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 697.5 99.8" style="enable-background:new 0 0 697.5 99.8;" xml:space="preserve" role="img" aria-label="Logo" aria-labelledby="mw-logo-title mw-logo-desc"> eLesor Logo Go to the homepage.

Coronavirus

Coronavirus

The latest news on COVID-19, the coronavirus disease that emerged in 2019.

Read full story

Is it time for Americans to drop their infatuation with the PCR test? That’s what this COVID-19 testing expert thinks

Read full story

Will we need COVID-19 booster shots? Increasingly, the expectation is yes

It looks like Americans may need to roll up their sleeves for a COVID-19 booster shot, though vaccine makers and federal officials are still trying to detect how long immunity to the virus lasts.

Read full story

Breakthrough infections in people who have gotten their COVID-19 shots are very rare. But here’s why Rick Bright wants the CDC to restart the sequencing of all viral strains.

Rick Bright is no stranger to pandemics. The virologist and immunologist has worked under four presidents.

Pandemic: Year 2

Read full story

How 6 feet became 3: Meet an ER doctor behind the research showing kids are still safe in school with new social-distancing standard

Dr. Elissa Schechter-Perkins is an emergency room physician at Boston Medical Center. She's also a co-author of a study that indicates three feet of spacing is just as safe for students as six feet of distance as long as t...

Read full story

U.S. COVID vaccine program faces setback with J&J jab, as experts say there is no cause for alarm

The U.S. COVID-19 vaccine program was facing a setback Tuesday, when the nation's two leading health agencies recommended a pause in the use of the Johnson & Johnson vaccine to allow their scientists investigate six cases ...

Read full story

Top official admits China’s COVID-19 vaccines have low effectiveness

In a rare admission of the weakness of Chinese coronavirus vaccines, the country's top disease control official says their effectiveness is low and the government is considering mixing them to get a boost.

Read full story

U.S. economy will boom into 2023, but inequality must be addressed: Jamie Dimon in his latest letter to JPMorgan shareholders

JPMorgan Chase & Co.'s Jamie Dimon published his annual letter to shareholders on Wednesday, and as usual offered a broad overview of the state of the world after a year of a global pandemic, homing in on the hardship it h...

Read full story

How dollar stores could provide a shot in the arm for the U.S.’s COVID vaccination drive

Research suggests Dollar General and Dollar Tree could be keys to more equitable vaccine distribution.

Read full story

Biden administration surging tests and vaccinators to Michigan, where COVID transmission rate is nation’s worst

Biden spoke with Gov. Gretchen Whitmer late Thursday about the current public health situation in her state.

Read full story

New unemployment claims jump to 719,000, but spike likely temporary as U.S. economy strengthens

New applications for U.S. unemployment benefits rose in late March, but they likely to be begin falling again soon as the economy revs up, governments loosen restrictions and companies seek to hire more workers. Initial j...

Read full story

CDC’s Dr. Walensky makes emotional plea to Americans as COVID cases rise again

The head of the Centers for Disease Control and Prevention made an emotional plea with the American public on Monday, describing her sense of "impending doom" as she urged people not to let their guard down as COVID-19 cas...

Read full story

Am I a jerk for getting a COVID-19 vaccine if I feel healthy and work from home?

Many people who qualify for the shots wrestle with whether they ‘deserve’ them or not. Here’s what ethicists have to say.

Read full story

It’s a ‘question of time’ before another virus jumps from animal to human, says co-inventor of flu treatment Tamiflu. Preventative therapies are needed.

Nobert Bischofberger helped discover Tamiflu, a well-known antiviral flu treatment. Here's why he thinks the U.S. hasn't put enough emphasis on preventative COVID-19 therapies.